Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524412 | NSE: AAREYDRUGS | Pharmaceuticals & Drugs | Small Cap

Aarey Drugs & Pharma Share Price

76.44 -4.01 -4.98%
as on 05-Dec'25 12:11

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524412 | NSE: AAREYDRUGS | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Aarey Drugs & Pharma

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Aarey Drugs & Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
63.65
Market Cap:
228.1 Cr.
52-wk low:
31.3
52-wk high:
100

Is Aarey Drugs & Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Aarey Drugs & Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarey Drugs & Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7.2%22.2%14.1%12.1%8.5%9.5%9.9%6.3%6.1%6.4%-
Value Creation
Index
-0.50.60.0-0.1-0.4-0.3-0.3-0.6-0.6-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 246396349355300348493419398474428
Sales YoY Gr.-60.9%-12%1.7%-15.4%16.1%41.4%-15%-5.1%19.2%-
Adj EPS 0.832.62.82.52.82.61.61.71.41.3
YoY Gr.-297.4%-15.6%9.4%-11.1%12.1%-7.6%-37.4%3.7%-16.2%-
BVPS (₹) 21.826.633.33638.541.343.945.346.547.851.1
Adj Net
Profit
1.35.566.55.86.56.54.14.744
Cash Flow from Ops. 5.70.6-20.40.72.95.50.5-1.3-310.3-
Debt/CF from Ops. 2.616.6-0.223.56.33.328.4-29.4-10.53.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.6%9.6%-1.3%19.2%
Adj EPS 7%-10.8%-18.3%-16.2%
BVPS9.1%4.4%2.9%2.9%
Share Price 11.8% 22.5% 25.1% 22.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.512.79.27.86.56.86.13.53.82.92.6
Op. Profit
Mgn %
0.42.42.22.21.11.32.321.60.60.4
Net Profit
Mgn %
0.51.41.71.81.91.91.311.20.80.8
Debt to
Equity
0.40.200.20.20.20.10.30.20.30
Working Cap
Days
166112148147191209166221259215113
Cash Conv.
Cycle
36246374543858836555

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Aarey Drugs & Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 1.3 -
TTM Sales (₹ Cr.) 428 -
BVPS (₹.) 51.1 -
Reserves (₹ Cr.) 117 -
P/BV 1.57 -
PE 63.65 -
From the Market
52 Week Low / High (₹) 31.30 / 100.00
All Time Low / High (₹) 0.50 / 143.95
Market Cap (₹ Cr.) 228
Equity (₹ Cr.) 28.4
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Aarey Drugs & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Aarey Drugs & Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Aarey Drugs & Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales246396349355300348493419398474
Operating Expenses 245386341347297344481411391471
Manufacturing Costs100225981110
Material Costs242383337341290334466398375454
Employee Cost 0000001111
Other Costs 2333546546
Operating Profit 110883511863
Operating Profit Margin (%) 0.4%2.4%2.2%2.2%1.1%1.3%2.3%1.8%1.6%0.6%
Other Income 33347733510
Interest 2422222345
Depreciation 1111112222
Exceptional Items 0000000000
Profit Before Tax 28897810656
Tax 1322123212
Profit After Tax 1567677454
PAT Margin (%) 0.5%1.4%1.8%1.8%1.9%1.9%1.3%0.9%1.2%0.8%
Adjusted EPS (₹)0.83.02.62.82.52.82.61.51.71.4
Dividend Payout Ratio (%)0%0%0%4%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 374878849097111115130136
Share Capital 17182323232325252828
Reserves 2030556167738690102108
Minority Interest0000000000
Debt1510316181814383135
Long Term Debt0000003432
Short Term Debt1410316181811332833
Trade Payables7275783778110110127129103
Others Liabilities 291188810111317
Total Liabilities 125142170146194233245291303291

Fixed Assets

Gross Block19242526273032333440
Accumulated Depreciation11121314151618192124
Net Fixed Assets 8121212121414141316
CWIP 0000000000
Investments 0000000012
Inventories251521171814293545
Trade Receivables72829510696162136190184133
Cash Equivalents 2130110121
Others Assets 4142446683780586892
Total Assets 125142170146194233245291303291

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 61-201350-1-310
PBT 28897810656
Adjustment 2533334457
Changes in Working Capital 1-10-29-9-6-5-10-9-12-1
Tax Paid 0-2-3-2-2-2-4-2-1-2
Cash Flow From Investing Activity -3-5-1-1-1-3-30-2-6
Capex -3-5-1-1-1-3-2-1-1-5
Net Investments 0-00000-11-1-1
Others 0-000000000
Cash Flow From Financing Activity -2423-2-2-2216-4
Net Proceeds from Shares 072400080112
Net Proceeds from Borrowing 0-00000-44-1-2
Interest Paid -2-4-2-2-2-2-2-3-4-5
Dividend Paid 000-0000000
Others 012-0-0-00-010
Net Cash Flow 1-12-300-011-0

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.5812.99.88.076.656.986.313.333.823.02
ROCE (%)7.2322.2114.1412.058.489.469.876.286.096.38
Asset Turnover Ratio2.052.962.242.251.771.632.061.561.341.6
PAT to CFO Conversion(x)60.2-3.330.140.50.710-0.25-0.62.5
Working Capital Days
Receivable Days1037193103123135110142172122
Inventory Days531019231912192931
Payable Days105708261721038610912593

Aarey Drugs & Pharmaceuticals Ltd Stock News

Aarey Drugs & Pharmaceuticals Ltd FAQs

The current trading price of Aarey Drugs & Pharma on 05-Dec-2025 12:11 is ₹76.44.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Aarey Drugs & Pharma stood at ₹228.1.
The latest P/E ratio of Aarey Drugs & Pharma as of 04-Dec-2025 is 63.65.
The latest P/B ratio of Aarey Drugs & Pharma as of 04-Dec-2025 is 1.57.
The 52-week high of Aarey Drugs & Pharma is ₹100.0 and the 52-week low is ₹31.30.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarey Drugs & Pharma is ₹428.3 ( Cr.) .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

The  company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.

Product range of the company includes: API/Intermediate

  • Metronidazol
  • Metronidazole Benzoate
  • 2 Methyl -5-Nitro Imidazole

Drug deliveryPharmaceuticals / Therapeutics

Therapeutic targets of the company's products are:

  • Allergy
  • Dermatology
  • Infectious Diseases

Recent development

Aarey Drugs & Pharmaceuticals  has recently informed that  Atul A Zatakia has resigned from the Company as a Director with effect from March 01, 2009.  

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×